(Bloomberg) — Sanofi agreed to acquire its messenger-RNA development partner Translate Bio Inc. for $3.2 billion, scooping up a biotech company steeped in the technology behind some of the worlds top-selling Covid-19 vaccines.
The French drugmaker will…
